Navigation Links
Nobel Spotlight on IVF Boosts Family Building Procedures
Date:10/13/2010

SEATTLE, Oct. 13 /PRNewswire/ -- With the Nobel prize for medicine awarded to Robert Edwards, the pioneer British biologist who developed in vitro fertilization (IVF) for humans, "any remaining doubts about the importance of 'test tube babies' that have lingered over the past 32 years ago should finally be put to rest," says Michael S. Opsahl, M.D., recently named one of "Washington State's Best Doctors" in Washington Magazine.

"IVF, once perceived as expensive and a last resort for infertile couples, is now considered a first-line infertility treatment because it works so well," said Opsahl of Northwest Center for Reproductive Sciences.

"I will never forget the birth of the first IVF baby July 25, 1978, because it was also my birthday and I had just graduated from med school. I was somewhat surprised by the paranoia that surrounded the birth," he said. "The idea of engineering super humans was far from our minds; curing infertility was foremost."

Later that year, Opsahl attended lectures by Professor Edwards and his partner, gynecologist Patrick Steptoe, now deceased. "It seemed to be almost science fiction—even for those of us in the field," he added.

"We will continue to have unresolved issues around rapidly changing scientific knowledge, especially with regard to assisted reproductive technologies, which sometimes elicit strong emotional opinions," he said. "In truth, we only proceed with thoughtful evidence-based steps. Best of all, long-term studies reassure us that IVF children are as healthy and intelligent as other children," Opsahl said.

Today, the national average for IVF success is approximately 30 percent, compared to 5 to 10 percent in the first decade of IVF. At NCRS, rates are 64 percent for women under 35; 48 percent for women 35 to 37; and 37 percent for women 38 to 40 (according to statistics collected during 2005-2009 for the Society for Assisted Reproductive Technology.)

About Northwest Center for Reproductive Sciences

With clinics in Kirkland and Seattle, NCRS is a partnership of senior physicians and scientists who have been honored with numerous accolades, such as Seattle Magazine's "Top Doctors." Senior staff members, including physicians, laboratory scientists and administrators, each possess over 20 years' experience in the reproductive medicine field. For additional information, visit http://www.nwreprosci.com.


'/>"/>
SOURCE Northwest Center for Reproductive Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene pioneers follow in Nobel footsteps
2. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
5. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
6. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
7. Thomson Reuters Predicts Nobel Laureates
8. Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements
9. Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel
10. BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge
11. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... and commercializing products to treat rare diseases where there ... will be hosting an Investor Webcast Event Friday, December ... of innate defense regulators (IDRs) as a new drug ... and the recently announced and published Phase 2 clinical ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selectorâ„¢ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... ROCHESTER, Minn. , Dec. 7, 2016  Vyriad ... McQuinn to the company,s Board of Directors. ... board as we build our business and develop our ... for cancer therapy," said Stephen Russell , MD, ... Mary Agnes , share our vision and passion for ...
Breaking Biology Technology:
(Date:11/15/2016)... 2016 Research and Markets has announced the ... report to their offering. ... The ... 2021 from USD 6.21 Billion in 2016, growing at a CAGR ... the bioinformatics market is driven by the growing demand for nucleic ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... , June 20, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... prisons involved, it has secured the final acceptance ... facilities for Managed Access Systems (MAS) installed. Furthermore, ... facilities to be installed by October, 2016. MAS ...
Breaking Biology News(10 mins):